Plavix and Necrosis ischaemic - a phase IV clinical study of FDA data

Summary:

Necrosis ischaemic is reported as a side effect among people who take Plavix (clopidogrel bisulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Coreg, and have Thrombolysis.

The phase IV clinical study analyzes which people have Necrosis ischaemic when taking Plavix. It is created by eHealthMe based on reports of 147,094 people who have side effects when taking Plavix from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,178 Plavix users. Check the latest studies of Plavix.

What is Necrosis ischaemic?

Necrosis ischaemic (death of cell due to lack of blood supply) is found to be associated with 97 drugs and 183 conditions by eHealthMe. Check the latest studies of Necrosis ischaemic.

On Jul, 07, 2026

147,094 people reported to have side effects when taking Plavix.
Among them, 13 people (0.01%) have Necrosis ischaemic.

Among these 13 people:

How long have people been on Plavix when they have Necrosis ischaemic? *

What is the gender of people who have Necrosis ischaemic when taking Plavix? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Necrosis ischaemic when taking Plavix? *

What are other drugs people take besides Plavix? *

What are other side effects people have besides Necrosis ischaemic? *

Pneumonia: 6 people, 46.15%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 38.46%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 5 people, 38.46%
Peripheral Vascular Disorder: 4 people, 30.77%
Diarrhea: 4 people, 30.77%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 30.77%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 30.77%
Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 30.77%
Aspartate Aminotransferase Increased: 4 people, 30.77%
Alanine Aminotransferase Increased: 4 people, 30.77%

What are the existing conditions these people have? *

Thrombolysis (resolving the blood clot): 4 people, 30.77%
Stress And Anxiety: 2 people, 15.38%
Osteitis (a general term for inflammation of bone): 2 people, 15.38%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 15.38%
Dyslipidaemia (abnormal amount of lipids): 2 people, 15.38%
Depression: 2 people, 15.38%
Chest Pain: 2 people, 15.38%
Mesenteric Vascular Insufficiency (insufficient vascular supply to mesenteric): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and have Necrosis ischaemic?

- Check whether Necrosis ischaemic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plavix:

Plavix (151,178 reports)

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Necrosis ischaemic:

Necrosis ischaemic (97 drugs)

Browse all the conditions that are associated with Necrosis ischaemic:

Necrosis ischaemic (183 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Plavix) and Plavix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.